Catheter-based drug delivery for restenosis

Advanced Drug Delivery Reviews

Volumn 24, Issue 1, 1997, Pages 31-43

  Eccleston, David S ^a   Lincoff, A Michael ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

angioplasty; catheter; coronary artery disease; local drug delivery; restenosis

Indexed keywords

BLOOD VESSELS; CARDIOLOGY; CATHETERS; DISEASES; DRUG DOSAGE; MEDICAL IMAGING;

ANGIOPLASTY; CORONARY ARTERY DISEASE; LOCAL DRUG DELIVERY; RESTENOSIS;

CONTROLLED DRUG DELIVERY;

ANTISENSE OLIGONUCLEOTIDE; HEPARIN; LIPOSOME; POLYMER; UROKINASE;

ANGIOPLASTY; ARTERY INJURY; ARTERY OCCLUSION; BALLOON CATHETER; BALLOON DILATATION; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DEVICE; DIFFUSION; DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; HUMAN; HYDROGEL; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; REVIEW; STENT;

EID: 0031568929     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(96)00480-2     Document Type: Review

References (92)

1. [1] Topol, E., Ellis, S., Cosgrove, D., Bates, E., Muller, D., Schork, N. and Loop, F. (1993) Analysis of coronary angioplasty practice in the United States with an insurance-claims data base. Circulation 87, 1489-1497.
2. [2] Report of a Working Party of the British Cardiac Society. (1991) Coronary angioplasty in the United Kingdom. Br. Heart J. 66, 325-331.
3. [3] Lincoff, A.M., Topol, E.J. and Ellis, S.G. (1994) Local drug delivery for the prevention of restenosis. Fact, fancy, and future. Circulation 90, 2070-2084.
4. [4] Hillegass, W.B., Ohman, E.M. and Califf, R.M. (1994) Restenosis: The Clinical Issues. In: Topol, E.J. (Ed). Textbook of Interventional Cardiology, Vol 2. WB Saunders, Philadelphia, PA, pp. 415-435.
5. [5] Lincoff, A.M., Popma, J.J., Ellis, S.G., Hacker, J.A. and Topol, E.J. (1992) Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J. Am. Coll. Cardiol. 19, 926-938.
6. [6] Popma, J.J., Califf, R.M. and Topol, E.J. (1991) Clinical trials of restenosis following coronary angioplasty. Circulation 84, 1426-1436.
7. [7] Forrester, J.S., Fishbein, M., Helfant, R. and Fagin, J. (1991) A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J. Am. Coll. Cardiol. 17, 758-769.
8. [8] Schwartz, R., Holmes, D. Jr. and Topol, E. (1992) The restenosis paradigm revisted: an alternative proposal for cellular mechanisms. J. Am. Coll. Cardiol. 20, 1284-1293.
9. [9] Topol, E., Leva, F., Pinkerton, C. Whitlow, P., Hofling, B., Simonton, C., Masden, R., Serruys, P., Leon, M. and Williams, D. (1993) A comparison of directional atherectomy with coronary angioplasty in patients with coronary-artery disease. N. Engl. J. Med. 329, 221-227.
10. [10] Teirstein, P.S., Warth, D.C., Haq, N., Jenkins, N.S., McCowan, L.C., Aubanel-Reidel, P., Morris, N. and Ginsburg, R. (1991) High speed rotational coronary atherectomy for patients with diffuse coronary artery disease. J. Am. Coll. Cardiol. 18, 1694-1701.
11. [11] Bittl, J., Sanborn, T., Tcheng, J., Siegel, R., Ellis, S. and The Percutaneous Excimer Laser Coronary Angioplasty Registry (1992) Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. Am. J. Cardiol. 70, 1533-1539.
12. [12] Fischman, D., Leon, M., Baim, D., Schatz, R., Savage, M., Penn, I., Detre, K., Veltri, L., Ricci, D. and Nobuyoshi, M. (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N. Engl. J. Med. 331, 496-501.
13. [13] Gal, D., Rongione, A.J., Slovenkai, G.A., DeJesus, S.T., Lucas, A., Fields, C.D. and Isner, J.M. (1990) Atherosclerotic Yucatan microswine: an animal model with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions. Am. Heart. J. 119, 291-300.
14. [14] Serruys, P.W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V. and Materne, P. (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N. Engl. J. Med. 331, 489-495.
15. [15] Fischman, D.L., Savage, M.P., Welsh, D.V., Wilson, P.M. and Goldberg, S. (1989) Tandem stenting in the treatment of diffuse coronary atherosclerotic disease: use of multiple Palmaz-Schatz stents. J. Invest. Cardiol. 1, 264-268.
16. [16] Ellis, S., Savage, M., Fischman, D., Baim, D., Leon, M., Goldberg, S., Hirshfeld, J., Cleman, M., Teirstein, P. and Walker, C. (1992) Restenosis after placement of Palmaz-Schatz stents in native coronary arteries: initial results of a multicenter experience. Circulation 86, 1836-1844.
17. [17] LeFevre, T., Morice, M., Zemour, G., Gaspard, P., Valeix, B., Pilliere, R., Bernard, A., Guerin, Y. and Henry, M. (1995) Stenting in Restenotic Coronary Arteries [abstract]. Eur. Heart J. 16, 287A.
18. [18] Popma, J.J., Califf, R.M. and Topol, E.J. (1991) Clinical trials of restenosis after coronary angioplasty. Circulation 84, 1426-1436.
19. [19] Ferrell, M., Fuster, V., Gold, H.K. and Chesebro, J.H. (1992) A dilemma for the 1990s: choosing appropriate experimental animal model for the prevention of restenosis [editorial comment]. Circulation 85, 1630-1631.
20. [20] Currier, J.W., Pow, T.K., Haudenschild, C.C., Minihan, A.C. and Faxon, D.P. (1991) Low molecular weight heparin (Enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit. J. Am. Coll. Cardiol. 17, 118B-125B.
21. [21] Faxon, D., Spiro, T., Minor, S., Douglas, J., Cote, G., Dorosti, K., Gottlieb, R., Califf, R., Topol, E. and Gordon, J. (1992) Enoxaprin, a low molecular weight heparin, in the prevention of restenosis after angioplasty: results of a double blind randomized trial. J. Am. Coll. Cardiol. 19, 258A.
22. [22] Muller, D.W.M., Ellis, S.G. and Topol, E.J. (1992) Experimental models of coronary artery restenosis. J. Am. Coll. Cardiol. 19, 418-32.
23. [23] Langer, R. (1990) New methods of drug delivery. Science 249, 1527-1533.
24. [24] Mitchel, J.F., Fram, D.B., Palme, D.F., Foster, R., Hirst, J.A., Azrin, M.A., Bow, L.M., Eldin, A.M., Waters, D.D. and McKay, R.G. (1995) Enhanced intracoronary thrombolysis with Urokinase using a novel, local drug delivery system. Circulation 91, 785-793.
25. [25] Nunes, G.L., Thomas, C.N., Hanson, S.R., Barry, J.J., King, S.B. and Scott, N.A. (1995) Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. Circulation 92, 1697-1700.
26. [26] Mitchel, J.F. and McKay, R.G. (1995) Treatment of acute stent thrombosis with local Urokinase therapy using catheter-based, drug delivery systems: a case report. Cathet. Cardiovasc. Diagn. 34, 149-154.
27. [27] Hong, M.K., Wong, S.C., Popma, J.J., Kent, K.M., Pichard, A.D., Satler, L.F., Mintz, G.S., Nikonow, K. and Leon, M.B. (1994) A dual-purpose angiophisty-drug infusion catheter for the treatment of intragraft thrombus. Cathet. Cardiovasc. Diagn. 32, 193-195.
28. [28] McKay, R.G., Fram, D.B., Hirst, J.A., Kiernan, F.J., Primiano, C.A., Rinaldi, M.J., Azrin, M.A., Mitchel, J.F. and Waters, D.D. (1994) Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: the Dispatch catheter. Cathet. Cardiovasc. Diagn. 33, 181-8.
29. [29] Camenzind, E., Vrolix, M., Hanet, C., Legrand, V., Bauters, C., Aengevaeren, W., Wijns, W., den Heijer, P., Blanchard, D., Montauban van Swijndregt, E., van der Meer, P., Melkert, R., Serruys, P. and DISPATCH Investigators (1995) Local heparin delivery following balloon angioplasty to prevent restenosis: Preliminary results from an open multicenter registry [abstract]. Circulation 92, I-346.
30. [30] Strauss, B.H., Chisholm, R.J., Keeley, F.W., Gotlieb, A.I., Logan, R.A., Armstrong, P.W. (1994) Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ. Res. 75, 650-658.
31. [31] Rensing, B.J., Hermans, W.R.M., Beatt, K.J., Laarman, G.J., Suryapranata, H,. van den Brand, M., de Feyter, P.J. and Serruys, P.W. (1990) Quantitative angiographic assessment of elastic recoil after percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 66, 1039-1044.
32. [32] Glagov, S. (1994) Intimal hyperplasia, vascular modeling, and the restenosis problem. Circulation 89, 2888-2891.
33. [33] Isner, J.M. (1994) Vascular remodeling: Honey, I think I shrunk the artery. Circulation 89, 2937-2942.
34. [34] Moore, S., Friedman, R., Singal, D., Gauldie, J., Blajchman, M. and Roberts, R. (1975) Inhibition of injury induced thromboatherosclerotic lesions by anti-platelet serum in rabbits. Thromb. Haemost. 35, 70-81.
35. [35] Topol, E., Califf, R., Weisman, H. and The Epic Investigators. (1994) Reduction of clinical restenosis following coronary intervention with early administration of platelet IIb/IIIa integrin blocking antibody. Lancet 343, 881-886.
36. [36] Clagett, G., Gention, E. and Salzman, H. (1985) Antithrombotic therapy in peripheral vascular disease. Chest 95, 128S-139S.
37. [37] Tomaru, T., Nakamura, F., Miwa, A., Fujimori, Y., Murata, Y., Kawai, S., Okada, R., Omata, M. and Uchida, Y. (1994) Prevention of thrombus formation by local delivery of antithrombotic agents [abstract]. J. Am. Coll. Cardiol. 23, 1-374A.
38. [38] Serruys, P.W., Rutsch, W., Heyndrickx, G.R., Danchin, N., Mast, E.G., Wijns, W., Rensing, B.J., Vos, J., Stibbe, J. and Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study Group (CARPORT) (1991) Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade - a randomized, double-blind, placebo-controlled trial. Circulation 84, 1568-1580.
39. [39] White, C., Knudson, M., Schmidt, D., Chisholm, R., Vandormael, M., Morton, B., Roy. L., Khaja, F., Reitman, M. and Ticlopidine Study Group. (1987) Neither ticlopidine nor aspirin-dipyridamole prevents restenosis post-PTCA: results from a randomized placebo controlled multicenter trial [abstract]. Circulation 76, IV-213.
40. [40] Sarembock, I.J., Gertz, D., Gimple, L.W., Owen, R.M., Powers, E.R. and Roberts, W.C. (1991) Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 84, 232-243.
41. [41] Casscells, W. (1993) Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 86, 723-729.
42. [42] Simons, M., Edelman, H., DeKeyser J.-L., Langer, R. and Rosenberg, R. (1992) Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 359, 67-70.
43. [43] Shi, Y., Fard, A., Galeo, A., Hutchinson, H., Vermani, P., Dodge, G., Hall, D., Shaheen, F. and Zalewski, A. (1994) Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation 90, 944-951.
44. [44] Lindner, V. and Reidy, M.A. (1991) Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. 88, 3739-3743.
45. [45] Casscells, W., Lappi, D., Olwin, B., Wai, C., Siegman, M., Speir, E., Sasse, J. and Baird, A. (1992) Elimination of smooth muscle cells in experimental restenosis: targeting of fihroblast growth factor receptors. Proc. Natl. Acad. Sci. USA 89, 7159-7163.
46. [46] Muller, D. (1994) Site-specific therapy for the prevention of restenosis. In: Topol, E.J. (Ed.). Textbook Of Interventional Cardiology, Vol 2. WB Saunders, Philadelphia, PA, pp. 436-448.
47. [47] Muller, D., Topol, E., Abrams, G., Gallagher, K. and Ellis, S. (1992) Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty. J. Am. Coll. Cardiol. 20, 460-466.
48. [48] Eskin, S., Meidall, R., McNatt, J., Buja, L., Sturgis, L., Gerard, R., Ferguson, J., Sambrook, J. and Willerson, J. (1991) Protective effect of mutant tissue plasminogen activator expressed from endothelial cells seeded on implanted stents [abstract]. Circulation 84, 11-399.
49. [49] Edelman, E.R., Adams, D.H. and Karnovsky, M.J. (1990) Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc. Natl. Acad. Sci. USA 87, 3773-3777.
50. [50] Okada, T., Bark, D. and Mayberg, M. (1989) Localized release of perivascular heparin inhibits intimal proliferation after endothelial injury without systemic anticoagulation. Neurosurgery 25, 892-898.
51. [51] Villa, A.E., Guzman, L.A., Poptic, E.J., Labhasetwar, V., D'Souza, S., Farrell, C.L., Plow, E.F., Levy, R.J., Di Corleto, P.E. and Topol, E.J. (1995) Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. Circ. Res. 76, 505-513.
52. [52] Edelman, E.R., Simons, M. and Sirois, M.G., Rosenberg, R.D. (1995) c-myc in vasculoproliferative disease. Circ. Res. 76, 176-82.
53. [53] Simons, M. (1994) Antisense technology. ACC Curr. J. Rev. July, 11-13.
54. [54] Villa, A., Guzman, L., Chen, W., Golomb, G., Levy, R. and Topol, E. (1994) Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J. Clin. Invest. 93, 1243-1249.
55. [55] Nabel, E.G., Plautz, G., Boyce, P.M., Stanley, J.C. and Nabel, G.J. (1989) Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 244, 1342-1344.
56. [56] Wolinsky, H. and Thung, S.N. (1990) Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J. Am. Coll. Cardiol. 15, 475-481.
57. [57] Wilensky, R.L., March, K.L. and Hathaway, D.R. (1991) Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty. Am. Heart J. 122, 1136-1140.
58. [58] van der Giessen, W., Violaris, A. and van Beusekom, H. (1994) Acute local delivery of drugs with incremental molecular size in normal coronary arteries of pigs [abstract]. Eur. Heart J. 15, 559.
59. [59] Simari, R., Srivatsa, S., Fitxpatirck, L. and Schwartz, R. (1994) Intracoronary delivery of antisense oligonucleotides: a comparison of techniques [abstract]. Restenosis Summit VI, Cleveland, OH, p. 26.
60. [60] Mitchel, J., Fram, D., Palme, D., Foster, R., Hirst, J., Azrin, M., Alberghini, T., Bow, L., Waters, D. and McKay, R. (1994) Enhanced intracoronary thrombolysis using the Dispatch catheter [abstract]. Circulation 90, 1-493.
61. [61] Fram, D., Mitchel, J., Azrin, M., Schwedick, M., Waters, D. and McKay, R. (1994) Local heparin delivery in porcine coronary arteries with the dispatch catheter: delivery, washout and effect on platelet deposition following balloon angioplasty [abstract]. Circulation 90, I-493.
62. [62] Desmet, W., Wilczek, K., DeScheerder, S., Cathapermal, S., De Geest, H., Foegh, M. and Piessens, J. (1995) Local delivery of angiopeptin using a new helicoidal drug delivery catheter results in high tissue concentrations in remote vessels with a similar degree of myointimal hyperplasia after angioplasty in porcine coronary arteries [abstract]. Eur. Heart J. 16, 229A.
63. [63] McKay, R.G., Fram, D.B., Hirst, J.A., Kiernan, F.J., Primiano, C.A., Rinaldi, M.J., Azrin, M.A., Mitchel, J.F. and Waters, D.D. (1994) Treatment of intracoronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: the Dispatch™ catheter. Cathet. Cardiovasc. Diagn. 33, 181-188.
64. [64] Cumberland, D., Gunn, J., Tsikaderis, D., Arafa, S. and Ahsan, A. (1994) Initial clinical experience of local drug delivery via a porous balloon during percutaneous coronary angioplasty [abstract]. J. Am. Coll. Cardiol. 23, 186A.
65. [65] Hong, M., Wong, S., Farb, A., Mehlman, M., Virmani, R., Barry, J. and Leon, M. (1993) Feasibility and drug delivery efficiency of a new balloon angioplasty catheter capable of performing simultaneous local drug delivery. Coron. Artery Dis. 4, 1023-1027.
66. [66] Gunn, J., Shepherd, L., Grohmann, H., Francis, S., Crossman, D. and Cumberland, D. (1995) Local delivery of antisense oligonucleotide via a double-skinned porous balloon: where does the drug go? [abstract]. Eur. Heart J. 16, 484A.
67. [67] Meyer, B.J., Fernandez-Ortiz, A., Mailhac, A., Falk, E., Badimon, L., Michael, A.D., Chesebro, J.H., Fuster, V. and Badimon, J.J. (1994) Local delivery of r-Hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Circulation 90, 2474-2480.
68. [68] Nunes, G.L., Hanson, S.R., King Sr. Sahatjian, R.A. and Scott, N.A. (1994) Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. J. Am. Coll. Cardiol. 23, 1578-83.
69. [69] Azrin, M.A., Mitchel, J.F., Bow, L.M., Alberghini, T.V., Peck, R., Fram, D.B., Waters, D. and McKay, R.G. (1993) Effect of local delivery of heparin on platelet deposition during in-vivo balloon angioplasty using hydrogel-coated balloons [abstract]. Circulation 88, I-310.
70. [70] Mitchel, J.F., Azrin, M.A., Pearsall, L., Curley, T., Alberghini, T., Bauer, H., Waters, D. and McKay, R. (1994) Effect of local delivery of urokinase on platelet deposition during in vivo balloon angioplasty using hydrogel-coated balloons [abstract]. J. Am. Coll. Cardiol. 23, I-5A.
71. [71] Gonashior, P., Deiol, S. and Maier, G. (1994) Feasability of local drug application with a new catheter [abstract]. J. Am. Coll. Cardiol. 23, I-188.
72. [72] Kaplan, A.V., Kermode, J., Grant, G., Klein, E., Vetter, J., Hinohara, T. and Simpson, J.B. (1994) Intramural delivery of marker agent in ex vivo and in vivo models using a novel drug delivery sleeve [abstract]. J. Am. Coll. Cardiol. 23, 187A.
73. [73] Fernandez-Ortiz, A., Meyer, B.J., Mailhac, A., Falk, E., Badimon, L., Fallon, J.T., Fuster, V., Chesebro, J.H. and Badimon, J.J. (1994) A new approach for local intravascular drug delivery: iontophoretic balloon. Circulation 89, 15I8-1522.
74. [74] Nordrehaug, J., Chronos, N. and Sigwart, U. (1994) A biocompatible phosphatidylcholine coating applied to metallic stents [abstract]. J. Am. Coll. Cardiol. 23, I-5A.
75. [75] Lincoff, A.M., Furst, J.G., Ellis, S.G. and Topol, E.J. (1994) Sustained local drug delivery by a novel intravascular eluting stent to prevent restenosis in the porcine coronary artery [abstract]. J. Am. Coll. Cardiol. 23, 18A.
76. [76] Lambert, T.L., Dev, V., Rechavia, E., Forrester, J.S., Litvack, F. and Eigler, N.L. (1994) Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Circulation 90, 1003-1011.
77. [77] Hong, M., Farb, A., Chiu Wong, S., Mehlman, M., Virmani, R., Barry, J. and Leon, M. (1994) Locally delivered microspheres in atherosclerotic arteries via a new channeled balloon PTCA catheter are retained intramurally for at least 24 hours [abstract]. J. Am. Coll. Cardiol. 23, I-19A.
78. [78] Dev, V., Zeng, H., Forrester, J.S., Eigler, N., Tian, Y., Mickey, A.J., Fishbein, M.C., Kupfer, J. and Litvack, F. (1994) Microspheres for drug delivery to the arterial wall: a study of kinetics, toxicity, and effects of coroticosteroid loaded microspheres [abstract]. J. Am. Coll. Cardiol. 23, 19A.
79. [79] Gradus-Pizlo, I., Wilenski, R. and March, K. (1993) Local delivery of biodegradable microparticles containing colchicine analogue does not block restenosis in atherosclerotic rabbit femoral arteries [abstract]. Circulation 88, I-311.
80. [80] Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V. and Langer, R. (1994) Biodegradable long-circulating polymeric nanospheres. Science 263, 1600-1603.
81. [81] Labhasetwar, V., Song. C., Humphrey, W., Shebuski, R. and Levy, R. (1995) Nanoparticles for site specific delivery of U-86983 in restenosis in pig coronary arteries. Proc. Int. Symp. Control. Release Bioact. Mater. 22, 182-183.
82. [82] Song, C., Labhasetwar, V., Guzman, L., Topol, E. and Levy, R. (1995) Dexamethasone-nanoparticles for intra-arterial localization in restenosis in rats. Proc. Int. Symp. Control. Release Bioact. Mater. 22, 444-445.
83. [83] Eccleston, D., Furst, J., Labhasetwar, V., Levy, R. and Lincoff, A. (1995) Local delivery of polymeric nanospheres containing heparin reduces platelet deposition in the porcine balloon injury model [abstract]. Circulation 92, I-670.
84. [84] Baker, J., Nikolaychik, V., Keane, S., Komorowski, R., Kushnaryov, V., Keelan, M. and Kipshidze, N. (1995) Fibrin adhesive: an ideal vehicle for local delivery of biomaterials? [abstract]. Eur. Heart J. 16, 423A.
85. [85] Asahara, T., Kato, T. and Amemiya, T. (1992) In vivo experimental study on photodynamic therapy for the prevention of restenosis. Circulation 86, 1-846.
86. [86] Gonschior, P., Fleuchaus, M. and Gerheuser, F. (1993) Local drug delivery and photodynamic therapy (PDT) in a restenosis model [abstract]. Circulation 88, 1-645.
87. [87] Wiedermann, J.G., Marboe, C., Amols, H., Schwartz, A. and Weinberger, J. (1994) Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. J. Am. Coll. Cardiol. 23, 1491-1498.
88. [88] Kipshidze, N., Sahota, H., Komorowski, R., Boerboom, L., Keelan, M. and Baker, J. (1994) Low power red laser light inhibits smooth muscle cell proliferation following balloon angioplasty [abstract]. J. Am. Coll. Cardiol. 23, I-472A.
89. [89] Waksman, R., Robinson, K.A., Crocker, I.R., Gravanis, M.B., Cipolla, G.D. and King, S.B. (1995) Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. Circulation 91, 1533-1539.
90. [90] Waksman, R., Robinson, K.A., Crocker, I.R., Gravanis, M.B., Palmer, S.J., Wang, C., Cipolla, G.D. and King, S.B. (1995) Intracoronary irradiation before stent implantation inhibits neointima formation in stented porcine coronary arteries. Circulation 92, 1383-1386.
91. [91] Avitall, B., Hare, J., Zander, G., Bockoff, C., Tchou, P., Jazayeni, M. and Akhtar, H. (1992) Iontophoretic transmyocardial drug delivery: A novel approach to antiarrhythmic drug therapy. Circulation 85, 1582-1593.
92. [92] Bohnet, A., Kranzhofer, A., Bea, F., Horch, B., Weidler, R., Oberhoff, M. and Karseh, K. (1995) Local delivery of low molecular weight heparin with an iontophoresis catheter for the prevention of restenosis [abstract]. Eur. Heart J. 16, 424A.